Opinions on drugs - Posted on Jan 05 2011
Reason for request
Reassessment of actual benefit and improvement in actual benefit under article R-163-21 of the Social Security Code.
The actual benefit is moderate.
Clinical Added Value
The Transparency Committee is of the opinion that the REMODULIN range of proprietary drugs provides a minor improvement in actual benefit (IAB IV) in the treatment of idiopathic pulmonary arterial hypertension for patients in functional class III.
Évaluation des médicaments